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H3K4me2Histone modiﬁcation (HM) patterns are widely applied to identify transcription factor binding regions (TFBRs).
However, how frequently the TFBRs overlap with genomic regions enriched with certain types of HMs and
which HMmarker is more effective to pinpoint the TFBRs have not been systematically investigated. To address
these problems, we studied 149 transcription factor (TF) ChIP-seq datasets and 33HMChIP-seq datasets in three
cell lines. We found that on average about 90% of the TFBRs overlap with the H3K4me2-enriched regions.
Moreover, the H3K4me2-enriched regions with stronger signals of H3K4me2 enrichment more likely overlap
with the TFBRs than those with weaker signals. In addition, we showed that the H3K4me2-enriched regions
together with the H3K27ac-enriched regions can greatly reduce false positive predictions of the TFBRs. Our
study sheds light on the comprehensive discovery of the TFBRs using the HeK4me-enriched regions, especially
when no good antibody to a TF exists.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Transcription factor binding regions (TFBRs) are genomic regions of
several hundred to several thousand base pairs long that contain tran-
scription factor binding sites (TFBSs). Under an experimental condition,
a transcription factor (TF) binds its TFBSs only in a small number of
TFBRs, although many more genomic regions may contain short DNA
segments exactly the same as its TFBSs [1]. The common pattern of
the TFBSs bound by a TF is usually called a motif, often represented as
a consensus sequence or a position weight matrix (PWM) [1,2]. The
binding of TFs to their TFBSs in the TFBRs can activate or repress the
transcriptional expression of genes near the TFBRs [3]. It is thus impor-
tant to discover TFBRs and TFBSs for a given TF.
Currently, a routine approach to discover TFBRs and TFBSs is to carry
out the chromatin immunoprecipitation followed by massive parallel
sequencing (ChIP-seq) experiments with a speciﬁc antibody against a
TF [4,5]. These TF-based ChIP-seq experiments can deﬁne potential
TFBRs that are enriched with the binding of this TF on the genome
scale, the so-called ChIP-seq peak regions. With several hundreds to
thousands of potential TFBRs, computational methods can then be
applied to discover TFBSs in these regions [6–12]. Although ChIP-seq
experiments with a speciﬁc antibody against a TF can be a powerful
means to deﬁne potential TFBRs and subsequently discover TFBSs, the), xiaoman@mail.ucf.edu (X. Li),
. This is an open access article underchallenge is that TF-speciﬁc antibodies remain unknown for the major-
ity of TFs [13]. Additional limitation is that it is still costly to perform
ChIP-seq experiments for all TFs under a given condition [14].
An alternative approach to discover TFBRs and TFBSs is based on
ChIP-seq experiments using antibodies against different histonemodiﬁ-
cation (HM)markers [15,16]. HM-enriched (HME) genomic regions are
widely used to deﬁne genomic signatures including two major types of
TFBRs, an enhancer and a promoter [15,17]. For instance, H3K4me1 has
been identiﬁed as an enhancer maker since genomic regions enriched
with H3K4me1 signiﬁcantly overlap with p300-deﬁned enhancer
regions; and H3K4me3 has been considered as a marker of active
promoters sinceH3K4me3 enriched genomic regions signiﬁcantly over-
lap with basal promoters deﬁned by the binding of RNA polymerase II
and TBP-associated factor 1 [15]. Different combinations of HMs are
also discovered to distinguish different genomic regions. For example,
H3K4me1 is used to distinguish active from poised enhancers when
combined with H3K27ac and H3K27me3 respectively [18–20]. Com-
pared with individual TF-based ChIP-seq experiments for TFBR identiﬁ-
cation, HM-based ChIP-seq experiments can potentially deﬁne the
binding regions of all active TFs under a given condition. Recently, sev-
eral studies [21–23] from the Encyclopedia of DNA Elements (ENCODE)
project [13] have considered both TF-based and HM-based ChIP-seq ex-
periments to study TFBRs. For instance, Wang et al. [23] predicted TF
binding motifs in most of the 457 TF-based ChIP-seq datasets and
studied the epigenomic and genomic patterns around the TFBSs of
these motifs. Arvey et al. [21] explored the contribution of DNA
sequence patterns, HMs, and open chromatin regions (OCRs) to cell-the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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the patterns of HMs, OCRs, and nucleosome positioning around the
summit of TF binding peaks and gene transcriptional start sites for 119
TFs. However, all these studies have not attempted to pinpoint the
TFBRs of all active TFs under an experimental condition using a small
number of HMs. It has thus not been systematically investigated that
how frequently the TFBRs overlap HME regions andwhich HMpatterns
are the most effective to pinpoint the TFBRs of all active TFs under an
experimental condition.
To address these questions, we surveyed 149 TF-based and 33
HM-based ChIP-seq experiments in three cell lines (GM12878,
K562, and HeLa-S3) from the ENCODE project [13]. For the convenience
of explanation, we named the HME regions corresponding to a certain
HM α as α regions. For example, an HME region corresponding to
H3K4me1 was simpliﬁed as an H3K4me1 region. We observed that in
the three cell lines, the average percentage of the TFBRs overlapping
with the H3K4me2 regions is from 83% to 90%, and that of the
H3K4me2 regions overlappingwith the TFBRs is from56% to 67%.More-
over, we noticed that the H3K4me2 regions with higher level of the
H3K4me2 enrichment tend to more likely overlap with the TFBRs
than the H3K4me2 regions with lower level of the H3K4me2 enrich-
ment. Similarly, the TFBRs with stronger TF binding signal are more
likely to overlapwith theH3K4me2 regions than the TFBRswithweaker
TF binding signal. In addition, we applied the knowledge learned above
to identify the TFBRs on the genome-wide scale and found that the
H3K4me2 regions together with the H3K27ac regions or OCRs can
greatly reduce false positive predictions of the TFBRs. Our study sug-
gests that computational methods may be developed in the future to
systematically discover TFBSs of almost all active TFs under a condition
with theH3K4me2 regions, especiallywhen no known antibody for a TF
is available.2. Results
2.1. The majority of potential TFBRs overlap with the same six types of HM
regions
Weﬁrst investigated the overlap of potential TFBRs andHME regions
for each TF with each combination of 1 to 11 types of HME regions in
two cell lines GM12878 and K562. Here the potential TFBRs were the
original ChIP-seq peak regions deﬁned by the ENCODE project [13,24]
(see the Methods section). Two regions were claimed to overlap if
they shared at least 1 bp.
For every HM combination that is composed of 1, 2,…, 11 HMs, we
calculated the percentages of the potential TFBRs that overlapped with
its HME regions. We observed that when the number of HMs in a HM
combination increases, the percentage of the potential TFBRs overlap-
ping with the HM combination also increases (Supplementary
Table S1). We also observed that the increased fraction (b0.1%) be-
comes negligible after six HMs in the combinations (Supplementary
Fig. S1). Therefore, we further studied the combination of six types of
HME regions. We found that the combination of the following 6 types
of HME regions overlaps with the most number of the potential TFBRs
in both GM12878 and K562 cells: H3K36me3, H3K9me3, H2AZ,
H4K20me1, H3K27me3, and H3K4me1 regions. We called these six
HMs as the covering HMs and the six types of HME regions as the cov-
ering HME regions. On average, for each TF, 92.93% and 96.88% of the
potential TFBRs overlap with the covering HME regions in GM12878
and K562, respectively (Supplementary Table S1). We applied the
hypergenometric testing to evaluate the signiﬁcance of the overlap be-
tween the potential TFBR and the covering HME regions (see the
Methods section). All TFs in GM2878 and K562 have small p-values
(b10−5) (Supplementary Table S2). This observation implies that
ChIP-seq experiments with the covering HMs are sufﬁcient to identify
almost all the potential TFBRs under a speciﬁc condition.The above observed percentage of overlapwas calculated for each TF
and then was averaged across all TFs. We also calculated the percent-
ages of overlap between the potential TFBRs and HME regions for all
TFs in each chromosome and then averaged across all chromosomes.
We found that on average,more than 92.71% and 94.62%of the potential
TFBRs overlap with the covering HME regions across all chromosomes
in GM12878 and K562, respectively (Supplementary Table S2), with
small p-values (b10−5) of overlapping in these two cell lines. Therefore,
the above overlap percentages are not affected by the different numbers
of the potential TFBRs of different TFs.
We then investigated whether alternative criteria of overlap affect
the above observation. Alternatively, we used 10%, 20%, …, 100% of
the length of the potential TFBRs as cutoffs to determine whether a po-
tential TFBR overlapped with a HME region (Fig. 1). Interestingly, even
when the cutoff was 100%, which meant that the potential TFBRs were
completely within the HME regions, we still noticed that 90.98% and
95.13% of the potential TFBRs overlap with the covering HME regions
in the two cells. So in the following,we only reported results of the over-
lap of at least 1 bp when we claimed the overlap of two regions.
Next, we studied whether alternative deﬁnitions of the potential
TFBRs affect the observed percentages. Instead of using the original
ChIP-seq peaks deﬁned by ENCODE as potential TFBRs [13], for each
TF, we deﬁned the ChIP-seq peak regions using CisGenome [25] and
model-based analysis of ChIP-seq (MACS) [26]. CisGenome uses a
ﬁxedwidthwindow that is shifted through the genome to ﬁnd enriched
regions of ChIP-seq tags,whileMACS empiricallymodels the shift size of
ChIP-Seq tags and uses it to improve the spatial resolution of predicted
TFBSs. For the CisGenome-deﬁned TFBRs, we observed that on average,
for a TF, 90.97% and 91.33% of the potential TFBRs overlap with the
covering HME regions in GM12878 and K562, respectively. Similarly,
for the MACS-deﬁned TFBRs, for a TF, we observed that the average
percentages of the potential TFBRs overlapping with the covering
HME regions are 92.73% and 91.65% in GM12878 and K562, respectively.
Therefore, different deﬁnitions of the potential TFBRs do not change the
conclusion: themajority of the potential TFBRs overlapwith the covering
HME regions.
Finally, we checked whether the above conclusion holds in other
cells. We used all available potential TFBR and HME regions in the
HeLa-S3 cell line from the ENCODE project [13]. Consistently, we
found that 97.45% of the potential TFBRs overlap with the covering
HME regions in HeLa-S3 (Supplementary Table S1), with p-values of
overlapping smaller than b10−5 for all TFs. In addition, adding additional
types of HME regions does not increase this percentage much. This
observation from the HeLa-S3 cell suggests that it is very likely to
pinpoint the TFBRs for all TFs under a speciﬁc condition with ChIP-seq
experiments only on the six HMs.
2.2. H3k4me2 reliably deﬁnes TFBRs
The above analyses suggest, in order to identify TFBRs under a given
condition, one can perform the six HM-based ChIP-seq experiments
under this condition. However, the cost of these experiments is relative-
ly high. Moreover, the number of the covering HME regions is so large
that the identiﬁcation of the TFBSs from these regions may be difﬁcult.
In addition, a large number of the potential TFBRs do not contain
TFBSs and are thus false TFBRs [22,26]. We thus further investigated
whether one type of HME regions already contained the majority of
the TFBRs.
To obtain the TFBRs, for each TF-based ChIP-seq experiment, we
used the known or predicted motif PWMs to scan the potential TFBRs
with different score cutoffs (see the Methods section). The potential
TFBRs with highly scored DNA segments (scores larger than the cutoff)
were deﬁned as TFBRs. Note that we may have missed certain TFBRs,
due to the lack of knowledge about cofactor motifs. However, with
many ChIP-seq experiments, we hope to minimize the number of
missed TFBRs. We considered all TFs with ChIP-seq experiments in the
Fig. 1. Overlap percentages of TFBRs and HME regions under different cutoffs. The overlap
percentages between TFBRs and the six covering HME regions were calculated with the
overlap cutoffs deﬁned as 1 bp, and 10%, 20%,.., 100% of the length of TFBRs in GM12878,
K562 and HeLa-S3 cells.
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in the TRANSFAC database [27], we computationally deﬁned their
motifs using a recently developed tool Dreme [7] (Supplementary
Table S3). For each TF, using three different score cutoffs, we deﬁned
TFBSs and TFBRs. Depending on the TF and the corresponding ChIP-
seq experiments, the number of the deﬁned TFBRs varies dramatically
(Supplementary Table S3).
With the TFBRs, we calculated the percentages of the TFBRs overlap-
pingwith a speciﬁc type of HME regions for each TF and obtained an av-
erage percentage across all TFs.We found that despite themuch shorter
length of the H3K4me2 regions, the H3K4me2 regions overlap with the
maximal percentages of the TFBRs under various score cutoffs in
GM12878 and HeLa-S3 (Table 1, Supplementary Table S4). Although
theH3K4me2 regions achieved the secondmaximal percentage of over-
lap with the TFBRs under various score cutoffs in K562, these percent-
ages are close to the maximal percentages achieved by the H2AZ.
Moreover, the number of the H2AZ regions is much larger than that of
the H3K4me2 regions, and the length of the H2AZ regions is much lon-
ger than that of the H3K4me2 regions. Therefore, we focused on the
H3K4me2 regions to study their overlap with the TFBRs. Under the
score cutoff of 0.85, on average, 87.87%, 85.45%, and 89.66% of the
TFBRs of a TF overlap with the H3K4me2 regions in GM12878, K562,
and HeLa-S3, respectively. For all TFs, the overlap of the TFBRs and the
H3K4me2 regions in the three cell lines was signiﬁcant. Because current
methods may not accurately deﬁne the boundary of HME regions
[28,29], we further extended each HME region to 500 bp on both
sides. We found that the H3K4me2 regions are still the best type of
HME regions to narrow down the TFBRs. We also calculated the per-
centage of the TFBRs overlapping with each type of HME regions for
each chromosome and averaged the percentages across all chromo-
somes.Wehad a consistent observation that the H3K4me2 regions usu-
ally overlap with the maximal percentage of the TFBRs under all cutoffs
in all cells (Supplementary Table S4). Therefore, we concluded that
~90% of the TFBRs overlap with the H3K4me2 regions. This conclusion
implies that for almost all TFs, nomatter whether their TF-speciﬁc anti-
bodies are available, one may be able to identify the majority of their
TFBRs with the H3K4me2-based ChIP-seq experiment.
We further investigated the location of the TFBSs relative to the
H3K4me2 regions. We found that more than 96% of the TFBSs were in
the H3K4me2 regions in the three cell lines, if the TFBRs overlap with
theH3K4me2 regions. In addition, the TFBSs tend to locate in themiddle
of theH3K4me2 regions, where the highest level of H3K4me2modiﬁca-
tion occurs (Fig. 2). This observation implies that one possible approachto discover motifs of all active TFs under a condition is to perform the
H3K4me2-based ChIP-seq experiments and then computationally iden-
tify TF binding motifs in the middle of the H3K4me2 regions. Focusing
on the central H3K4me2 regions will certainly miss many TFBSs. How-
ever, since most TFBSs of a TF occur in the middle H3K4me2 regions, it
is likely that the motifs of active TFs could be identiﬁed.
We also compared the H3K4me2 regions with OCRs in terms of the
percentages of overlapped the TFBRs. OCRs have been widely used to
identify the TFBRs [30–32]. There are 195,014 (79,675), 239,971
(70,379), and 223,512 (81,013) OCRs (H3K4me2 regions) in
GM12878, K562, and HeLa-S3 cells, respectively. We found that
88.46% (88.98%), 89.04% (89.98%), and 90.58% (88.61%) of the TFBRs
overlap with OCRs (H3K4me2 regions) in the three cell lines, respec-
tively. That is, the percentages of the TFBRs overlapping with OCRs are
similar to those with the H3K4me2 regions, despite the much smaller
number of the H3K4me2 regions. However, the percentages of the
H3K4me2 regions overlapping the TFBRs were much larger than that
of OCRs (Fig. 3). For instance, 56.22%, 67.10%, and 56.34% of the
H3K4me2 regions, comparedwith 31.60%, 33.67%, 25.61% of OCRs, over-
lap with the TFBRs in GM12878, K562, and HeLa-S3, respectively. Since
the average length of OCRs is about 300 bpwhile cis-regulatory regions
have an average length of 600 bp or longer [9,33], we further extended
theOCRs to 600, 800, and 1000 bp, respectively.We found that although
the sum of lengths of the extended OCRs is much larger than that of the
H3K4me2 regions, the percentages of the H3K4me2 regions overlap-
ping the TFBRs were much larger than that of the extended OCRs (Sup-
plementary Table S5). Therefore, the H3K4me2 regions may be more
speciﬁc to the TFBSs and TFBRs than OCRs.
2.3. Non-overlapping TFBR and HME regions have relative weaker signals
compared with overlapped ones
We observed that a fraction of the above covering HME regions do
not overlap with the TFBRs. Similarly, a small portion of the above
TFBRs does not overlap with the covering HME regions or the
H3K4me2 regions. Therefore, we investigated the differences between
the overlapped regions and the non-overlapped regions.
We compared the q-values of enrichment of HM signals in the cov-
ering HME regions that overlap with the TFBRs with those that do not
overlap with the TFBRs. Here a q-value is the minimum false discovery
rate at which an observed enrichment of HM signals in a HME region
that is deemed signiﬁcant. The q-values were deﬁned by the ENCODE
project [13]. The statistical signiﬁcance of the HM signal difference is
measured by the p-values from the Wilcoxon rank-sum test [34]. For
each TF in the three cell lines, we found that the overlapped regions al-
ways have stronger HM signals (smaller q-values) than the non-
overlapping regions (Supplementary Table S6). The largest p-value for
all TFs in the three cell lines is 4.36E−12, which demonstrates that
the majority of non-overlapping regions have weaker HM signals and
thusmay be false HME regions. This also implies that TF binding prefers
to occur in covering HME regionswith stronger HM signals than in cov-
ering HME regions with weaker HM signals.
We also compared the q-values of enrichment of TF binding in the
TFBRs that overlap with the covering HME regions and those in the
TFBRs that do not overlap (Supplementary Table S6). For 115 out of
149 TF-based ChIP-seq experiments in the three cell lines, the overlap-
ping the TFBRs have signiﬁcantly more TF binding signals than the
non-overlapping TFBRs (Wilcoxon rank-sum test p-value b 0.05 [34]).
For the remaining 35 experiments, there are two cases. One is the 31
ChIP-seq experiments in which the number of non-overlapping regions
is too small (b20) for effective comparison of the non-overlapping re-
gions with the overlapping regions. The other is the 3 ChIP-seq experi-
ments for TFs GATA1 and ZNF274 in K562 and GTF3C2 in HeLa-S3.
The three exceptionsmay be caused by the quality of the antibodies, be-
cause there is another ChIP-seq experiment for GATA1 using a different
antibody, which has a smaller p-value of 0.035.
Table 1
The overlapped percentage of TFBRs with H3K4me2 regions.
Cutoffs GM12878 K562 HeLa-S3
0.8 0.85 0.9 0.8 0.85 0.9 0.8 0.85 0.9
H3K4me2 regions 87.13% 87.87% 90.48% 85.03% 85.45% 87.76% 89.43% 89.66% 90.14%
Extended H3K4me2 regions 88.29% 88.98% 91.41% 86.16% 86.54% 89.02% 90.51% 90.71% 91.15%
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the TFBRs that overlap with the H3K4me2 regions with those in the
TFBRs that do not overlap (Supplementary Table S6). For 132 out of
149 TF-based ChIP-seq experiments in the three cell lines, the overlap-
ping TFBRs have more TF binding signals than the non-overlapping
TFBRs (Wilcoxon rank-sum test p-value b 0.05). For the remaining 17
experiments, 7 experiments have a small number of non-overlapping
regions that is smaller than 20; and 10 experiments for the TFs
GATA1, ZNF274, ZNF263, E2F4, STAT2 andMYC in K562, and SMARCC1,
E2F6, ZNF274 in HeLa-S3 have large p-values. Again, we observed that
three ChIP-seq experiments for the TFs GATA1, MYC, and STAT2 had a
much smaller p-value (b0.014) when alternative antibodies were used.
We further compared the TFBRs that overlap with the H3K4me2 re-
gions with the TFBRs that do not overlap with the H3K4me2 regions.
Consistently, we observed that almost in all ChIP-seq experiments, the
overlapped TFBRs have much more TF binding signals than the non-
overlapped regions (Supplementary Table S7).
2.4. H3k4me2 regions together with H3K27ac or FAIRE OCRs signiﬁcantly
reduce false positive prediction of TFBRs
Observing that themajority of the TFBRs overlapwith the H3K4me2
regions, we attempted to discover the TFBRs containing the TFBSs of a
TF directly in the H3K4me2 regions using the known TF PWMs. We
studied three TFs, CHREBP, FOXA1, and SREBF1, whose TFBRs are exper-
imentally determined in HepG2 cells [35–37].
We ﬁrst studied whether the TFBRs deﬁned by TF-based ChIP-seq
experiments for the three TFs overlap with the H3K4me2 regions in
HepG2. We found that 95.49% (1100 out of 1152) of CHREBP, 87.56%
(7156 out of 8173) of FOXA1, and 91.74% (955 out of 1041) of SREBF1
potential TFBRs overlap with the H3K4me2 regions in HepG2. With
the score cutoff of 0.85 to deﬁne the TFBSs and TFBRs, we found that
97.17% of CHREBP, 89.71% of FOXA1, and 93.47% of SREBF1 TFBRs areFig. 2. TFBSs tend to locate in the middle of H3K4me2 regions. The percentages of TFBSs
that fall into different subregions in H3K4me2 regions were shown, where each
H3K4me2 region was normalized to have a unit length.inside the H3K4me2 regions. Therefore, consistent with the above
three cell lines, themajority of the TFBRs overlapwith the H3K4me2 re-
gions in HepG2 cells.
Since the number of the H3K4me2 regions is much larger than that
of the TFBRs of a TF, we next attempted to predict the TFBRs of the
three TFs in HepG2 from the H3K4me2 regions. We deﬁned the
H3K4me2 regions containing putative TFBSs of a TF as the predicted
TFBRs. We then wanted to select the predicted H3K4me2 regions that
overlap with the TFBRs of this TF by using the following eight features
(Table 2): H3K4me1, OCRs from DNase I hypersensitive experiments
(DNase I OCRs), OCRs from FAIRE experiments (FAIRE OCRs), OCRs
from synthesized DNase I hypersensitive sites and FAIRE (synthesized
OCRs), H3K27me3, H3K27ac, DNA methylation sites, and signal
strength of the H3K4me2 regions. Here the synthesized OCRs are the
combined high quality OCRs from the DNase I OCRs, the FAIRE OCRs,
and others by the ENCODE project [13].We found that H3K27ac togeth-
er with the H3K4me2 regions can signiﬁcantly reduce the false positive
prediction of the TFBRs (Fig. 4). For instance, for the TF SREBF1, only
26,431 out of 51,245 of the predicted TFBRs (H3K4me2 regions contain-
ing the putative SREBF1 TFBSs) overlap with the H3K27ac regions,
which showed higher speciﬁcity and sensitivity than other features
(Supplementary Table S8). We also noticed that FAIRE OCRs together
with the H3K4me2 regions can achieve similar speciﬁcity and
sensitivity.
Finally, we studied all TFs with TF-based ChIP-seq experiments in
GM12878 and K562. On average, for a TF, the overlap required of the
H3K4me2 regions and H3K27ac regions had the speciﬁcity of 35.46%
and 35.36% and the high sensitivity of 91.64% and 91.98% in GM12878
and K562, respectively (Supplementary Table S8), Consistently, we ob-
served that the overlap of the H3K4me2 regions and FAIRE OCRs can
achieve the speciﬁcity 48.95% and 32.18%, and the sensitivity of
84.11%, 93.68% in GM12878 and K562, respectively. Combining these
two features H3K27ac and FAIRE OCRs, we can have the speciﬁcity of
59.07% and 46.97%, and the sensitivity of 79.36% and 88.56% in
GM12878 and K562, respectively.
3. Discussion
We systematically studied the overlap of the TFBR and HME regions
in the three cell lines. We observed that more than 92% of the potential
TFBRs overlap with the covering HME regions in different cell lines. The
potential TFBRs that do not overlapwith the coveringHME regions have
signiﬁcantly weaker TF binding signals compared with the overlapped
potential TFBRs. We also noticed that on average close to 90% of the
TFBRs overlap with the H3K4me2 regions under various parameters in
the three cell lines. The TFBSs tend to be located in the middle of the
H3K4me2 regions. Finally, we showed that the H3K4me2 regions to-
getherwith the H3K27ac regions or FAIREOCRs can signiﬁcantly reduce
false positive predictions of the TFBRs. Our study shed light on the sys-
tematic studies of the TFBRs for all active TFs under a speciﬁc condition.
Our study is different from that in ChromHMM [38] and Segway
[39]. The ultimate goal of our study is to narrow down the TFBRs of a
TF with only one histone modiﬁcation. ChromHMM and Segway used
combinations of multiple histone modiﬁcations to divide the genomes
into different regions with different functional characteristics. With
that said, ChromHMM and Segway do not aim to cover most of the
TFBRs of a TF by one state. They also did not analyze the overlap of
their predicted states with the TFBRs of all TFs with ChIP-seq data
Fig. 3. Comparison of H3K4me2 regionswith OCRs. (A)–(C), the percentages of H3K4me2 regions, FAIREOCRs, DNase I OCRs, andOCRs overlappingwith TFBRs of a given number of TFs in
GM12878, K562 andHeLa-S3 cells. OCRs are also called synthesized OCRs by the ENCODEproject. The x-axis gives the number of TFs used for calculating the percentages. (D)–(F), for each
TF in GM12878, K562 and HeLa-S3 cells, the percentages of TFBRs overlap with H3K4me2 regions, FAIRE OCRs, DNase I OCRs, and OCRs. The x-axis provides the TF index number used in
calculating the percentages.
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given TF in our study may be a subset of the combination of multiple
chromatin states predicted by ChromHMM or Segway. For example, in
cell lines GM12878 and K562, on average, about 96.61% and 94.45%
TFBRs predicted from the H3K4me2 regions overlapped with predicted
(active/weak/poised) promoters or enhancers (states 1–7).
In addition to the factors mentioned in the Results section that may
affect the overlap percentage of the potential TFBR andHME regions, we
also checked howdifferent deﬁnitions of HME regions affect the overlap
percentages. Among the several available tools we tried, wemanaged to
deﬁne HME regions by another tool, SICER [29]. The overlap percentage
was reduced by 12.85% and 9.13% in the GM12878 and K562, respec-
tively. However, the majority (more than 88% in K562) of the potential
TFBRs still overlap with the covering HME regions.
The above overlap percentages are robust in terms of different cell
types. In addition to the above analyses, we studied all other ENCODE
cell lines with at least 10 TF-based ChIP-seq datasets and the 11 HM-
based ChIP-seq datasets. HepG2 and H1-hESC are the only two other
cell lines. On average, the same covering HME regions overlap with
more than 92% of the potential TFBRs of a TF in these two cell lines.
The above overlap percentages may be underestimated. This is be-
cause current computational methods still cannot perfectly deﬁne the
boundary of HME regions. We may thus need to extend the current
HME regions to calculate the overlap percentages, as what was shown
for the extended H3K4me2 regions. Moreover, variation exists among
similar or replicated ChIP-seq experiments. For instance, a recent
ChIP-seq experiment using the antibody against the TF CTCF only recov-
ered 94.5% of the previously reported CTCF TFBRs in the same cell [40].
Thus, the overlap of 96.88% in K562 may already represent the 100%overlap. In addition, the quality of the antibody used may decrease the
overlap percentages. As mentioned above, for several TFs, the overlap
percentage is signiﬁcantly larger when using one antibody than another
antibody. Finally, many non-overlapping regions may be incorrectly
deﬁned as the TFBR or HME regions, as we have shown that non-
overlapping regions have weaker signals compared with overlapping
regions.
Our comparison of OCRs with the H3K4me2 regions shed light on
how to systematically identify the TFBRs under a given condition.
OCRs are widely used to map the regulatory regions, which include
both the TFBRs and others. Our analysis shows that the H3K4me2 re-
gions aremore speciﬁc to the TFBRs thanOCRs. It is thusmore appealing
to carry out one ChIP-seq experiment using an antibody against
H3K4me2 instead of two experiments to deﬁne the DNase I hypersensi-
tiveOCRs and FAIREOCRs.However, it is also evident that the number of
H3K4me2 regions is much larger than the number of the TFBRs of a TF.
Computational methods [44,45] should thus be developed to identify
true TFBRs by integrating the H3K4me2 signals and the genomic se-
quence information within the large number of H3K4me2 regions.
4. Methods
4.1. TF-based and HM-base ChIP-seq data
We downloaded ChIP-seq data from the hg19 version of ENCODE
production data at the University of California Santa Cruz (UCSC)
genome browser [41]. Each peak dataset contains the peak location,
the q-value, and the mapped reads of each peak in the dataset. The
q-value of a peak here is the minimum false discovery rate if the
Fig. 4. Reduce false positive predicted TFBRs using H3K27ac regions. For each TF, the H3K4me2 regions containing its putative TFBSs were deﬁned as predicted TFBRs. We then used the
predicted TFBRs that overlap with H3K27ac regions as the ﬁnal predicted TFBRs. TP: true positive; FP: false positive; FN: false negative; TN: true negative.
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which describes the statistical signiﬁcance of the enrichment of aHMor a
TF binding in the peak. The q-valueswere deﬁned by the ENCODE project
[13].
All available ChIP-seq peak data for HMswere downloaded fromEN-
CODE/Broad Institute (hg19). Therewere 11HMmarkers for each of the
three cell lines, GM12878, K562 and HeLa-S3. These 11 HMmarkers are
H3K9me3, H3K4me2, H3k27ac, H3K4me1, H3K9ac, H3K4me3, H2A.Z,
H4K20me1, H3K27me3, H3K36me3, and H3K79me2. For the HepG2
cell, we downloaded the H3K4me2 ChIP-seq peaks from ENCODE/
Broad Institute (hg19) as well. We called genomic regions correspond-
ing to these ChIP-seq peak HME regions. We also downloaded the
mapped reads from these ChIP-seq experiments.We then deﬁned an al-
ternative set of ChIP-seq peaks by using the tool SICER with the default
parameters [29].
All available ChIP-seq peak data for the TFs in the above three cell
lines were downloaded from ENCODE/SYDH TFBS (hg19) at the UCSC
genome browser. With different treatments and controls, there are in
total 36, 70, 43 ChIP-seq peak datasets, corresponding to 35, 51, and
41 TFs, in GM12878, K562, and HeLa-S3, respectively. We called geno-
mic regions corresponding to these ChIP-seq peak potential TFBRs. We
also downloaded the mapped reads data from these ChIP-seq experi-
ments. We deﬁned two sets of alternative ChIP-seq peaks by using the
tools CisGenome [25] and MACS [26] with the default parameters,
respectively.
For the three TFs in the HepG2 cells, CHREBP, FOXA1, and SREBF1,
we downloaded their ChIP-seq data from the published papers
[37,42,43].
4.2. OCRs and other data
Wedownloaded OCRs from the hg19 version of ENCODE production
data at the UCSC genome browser [41]. We used the Duke DNase I hy-
persensitive sites as DNase I OCRs. We used the UNC FAIRE as FAIRE
OCRs. We used the “Open Chrom Synth” as the synthesized OCRs.
Similarly, we used DNA methylation data from the ENCODE projectgenerated by HudsonAlpha (hg19). We used all TF motifs deﬁned in
the TRANSFAC 9.2 database [27]. In total, 25 TFs have known motifs in
TRANSFAC in GM12878, K562, and HeLa-S3 cells.
4.3. Identiﬁcation of motifs and TFBSs
For TFs with no known motifs, we applied a motif discovery tool
DREME [7] to the top 100 TF ChIP-seq peaks. We used the top one
motif predicted by DREME that was not a simple-repeat-like pattern
as the deﬁned motif of the corresponding TF. We used the predicted
PWMs to represent motifs.
To deﬁne TFBSs,we scannedDNA sequences corresponding to the TF
ChIP-seq peaks (we called them the potential TFBRs) with the
corresponding known or deﬁned motif PWMs. For a motif PWM, say
M= (mij)k × 4 where k is the motif length, we calculated the score of a
DNA segment s1s2 … as follows:
∑ki¼1 ∑
4
j¼1mijIsi¼ j− minj mij
 
∑ki¼1 max
j
mij− min
j
mij
  . Here
Isi¼ j is an indicator function, which is 1 when si is the j-th type of nucle-
otides and 0when it is not. A DNA segment of length k is called a TFBS if
its score is larger than a score cutoff. We used three different cutoffs,
0.80, 0.85, and 0.90, to deﬁne TFBSs in the potential TFBRs of a TF. A
potential TFBR containing at least one TFBS is deﬁned as a TFBR.
4.4. Calculation of overlapping p-value
We calculated the signiﬁcance of the overlapping percentage of two
types of regions by the hypergeometric testing. This testing has four pa-
rameters, N, M, n, andm. N is the number of individuals in a population,
M is the number of individuals with a certain feature, n is the number of
chosen individuals, and m is the number of chosen individuals with the
feature. For the overlap of the covering HME regions and the potential
TFBRs of a TF, we used the sum of the number of all 11 types of HME re-
gions and the number of potential TFBRs of all TFs as N, the number of
the covering HME regions as n, the number of potential TFBRs of a TF
228 Y. Wang et al. / Genomics 103 (2014) 222–228asM, and the number of the coveringHME regions overlappingwith the
potential TFBRs of the TF under consideration asm. For the overlap of the
H3K4me2 regions and the TFBRs of a TF, N andMare similar as above, n is
the number of the H3K4me2 regions, and m is the H3K4me2 regions
overlapping with the TFBRs of the TF under consideration.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.ygeno.2014.02.002.
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